GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Human Health Holdings Ltd (HKSE:01419) » Definitions » Cash Conversion Cycle

Human Health Holdings (HKSE:01419) Cash Conversion Cycle : 16.41 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Human Health Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Human Health Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 46.36.
Human Health Holdings's Days Inventory for the six months ended in Dec. 2023 was 36.03.
Human Health Holdings's Days Payable for the six months ended in Dec. 2023 was 65.98.
Therefore, Human Health Holdings's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 16.41.


Human Health Holdings Cash Conversion Cycle Historical Data

The historical data trend for Human Health Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Health Holdings Cash Conversion Cycle Chart

Human Health Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.96 10.49 57.24 89.99 72.64

Human Health Holdings Semi-Annual Data
Jun13 Jun14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.05 50.06 79.30 90.81 16.41

Competitive Comparison of Human Health Holdings's Cash Conversion Cycle

For the Medical Care Facilities subindustry, Human Health Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Health Holdings's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Human Health Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Human Health Holdings's Cash Conversion Cycle falls into.



Human Health Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Human Health Holdings's Cash Conversion Cycle for the fiscal year that ended in Jun. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=95.46+20.84-43.66
=72.64

Human Health Holdings's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=46.36+36.03-65.98
=16.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Human Health Holdings  (HKSE:01419) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Human Health Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Human Health Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Health Holdings (HKSE:01419) Business Description

Traded in Other Exchanges
N/A
Address
12th Floor, 3 Sheung Yuet Road, Phase 2, Enterprise Square Two, Kowloon Bay, Kowloon, Hong Kong, HKG
Human Health Holdings Ltd is engaged in the provision of healthcare services. The company segments include general practice services, specialties services, and dental services. It offers general practice services, including general consultation, diagnostics, and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Cardiology, Dental Implant, Urology, work injury assessment services, Orthodontics and others. The company generates maximum revenue from the general practice services segment.
Executives
Bei Jing Feng Huang Lian He Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Xu Jie 2201 Interest of corporation controlled by you
Treasure Group Global Limited 2101 Beneficial owner
Capital Healthcare International Limited 2101 Beneficial owner
Chan Kin Ping 2201 Interest of corporation controlled by you
Pang Lai Sheung 2201 Interest of corporation controlled by you
Shou Du Yi Liao Jian Kang Chan Ye Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you

Human Health Holdings (HKSE:01419) Headlines

No Headlines